Form 10-Q Roivant Sciences Ltd. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/30/2026
- Wall St set for strongest quarter in years as risk appetite holds despite US-Iran war
- Dollar pushes higher, yen sinks to 40-year low
- Citi says bearish flows are building in Nasdaq and S&P 500
- Patrick and LCI Industries to merge in all-stock deal
- Logitech dips as BofA downgrades stock on demand outlook concerns
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
- New leader board: Citi refreshes AI compute semiconductor picks
- Honeywell completes aerospace spin-off, splits into 3 companies
Roivant Sciences (ROIV) PT Raised to $26 at Citi
November 10, 2025 3:58 PM ESTCiti analyst Samantha Semenkow raised the price target on Roivant Sciences (NASDAQ: ROIV) to $26.00 (from $25.00) while maintaining a Buy rating.
Removes 90-Day Upside Catalyst Watch... More